MedTrace Logo

A Placebo-Controlled Study Evaluating the Effects of Arrabina on Satiety in Healthy Adults

NCT06884449 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2026-02-19

No results posted yet for this study

Summary

This study is being conducted to assess the effects of a prebiotic product, Arrabina, on appetite in healthy adults. The goal is to see if this product can help with appetite regulation, support gut health, and support weight management.

Conditions

  • Satiety
  • Appetite Regulation
  • Weight Control

Interventions

DIETARY_SUPPLEMENT

Arrabina Prebiotic 5.0 g

Active Powder

DIETARY_SUPPLEMENT

Arrabina Prebiotic 3.5 g

Active Powder

OTHER

Placebo

Placebo Powder

Sponsors & Collaborators

  • Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

    collaborator NETWORK

  • Comet Bio Inc.

    lead INDUSTRY

Principal Investigators

  • Andrew Richard · Comet Biorefining Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-15
Primary Completion
2025-10-20
Completion
2025-10-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06884449 on ClinicalTrials.gov